๐๏ธ Verified NIH Record โข Updated 2026-05-11
Cochlear Implant Speech in Noise Processing (NCT06860152)
O15-PET Imaging of Cochlear Implant Speech in Noise Processing
๐ข Recruiting Observational / Diagnostic โ๏ธ Medical Device Protocol Sponsor: Craig D. Workman, PhD
๐ฉบ Plain-English Summary (8th-Grade Level)
The study will help us in understanding the neural mechanisms by which listeners with a cochlear implant detect speech in noisy environments.
Who can join: Review the eligibility criteria below.
Location: University of Iowa โ Iowa City, Iowa
Age range: 18 Years to 99 Years
๐งช Interventions in This Study
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (1 Sites)
- University of Iowa โ Iowa City, Iowa
๐ Contact the Study Coordinator
Phone: (319) 384-5468
Email: craig-workman@uiowa.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Hearing Loss, Adult-Onset
- Hearing Healthcare Assessment in Rural Communities โ Campbellsville, Kentucky
- Hearing Loss and Brain Health Study โ Los Angeles, California
- Use of Airpod Pros as Assistive Technology โ Richardson, Texas
Explore by condition: All Hearing Loss, Adult-Onset clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.